Showing results (711-720 of 881) with videos related to
Sort By:
Pageof 89
Open Forum Infectious Diseases|April 21, 2021
T-cell Activation Is Correlated With Monocyte Activation in HCV/HIV Coinfection and Declines During HCV Direct-Acting Antiviral TherapyAnn W N Auma, Carey Shive, Sofi Damjanovska, et al.American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 23, 2023
Outcomes of early vs late treatment initiation in solid organ transplantation from hepatitis C virus nucleic acid test-positive donors to hepatitis C virus-uninfected recipients: Results from the HCV-TARGET studyWesam Aleyadeh, Elizabeth C Verna, Hany Elbeshbeshy, et al.Kidney International Reports|February 19, 2019
Ombitasvir, Paritaprevir, Ritonavir, and Dasabuvir With or Without Ribavirin in Patients With Kidney DiseaseDavid E Bernstein, Albert Tran, Paul Martin, et al.Journal of Hepatology|October 27, 2010
Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patientsMarie-Louise C Vachon, Stephanie H Factor, Andrea D Branch, et al.International Journal of Surgery (London, England)|January 21, 2017
Age-related differences pre-, intra-, and postcholecystectomy: A retrospective cohort study of 6,868 patientsHadia Maqsood, Kalpesh Patel, Hamid Ferdosi, et al.The Journal of Infectious Diseases|June 8, 2014
Interferon γ-induced protein 10 kinetics in treatment-naive versus treatment-experienced patients receiving interferon-free therapy for hepatitis C virus infection: implications for the innate immune responseJennifer C Lin, François Habersetzer, Maribel Rodriguez-Torres, et al.Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 7, 2011
Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3Samir R Shah, Keyur Patel, Patrick Marcellin, et al.Open Forum Infectious Diseases|May 4, 2019
A Randomized Controlled Trial of Cash Incentives or Peer Support to Increase HCV Treatment for Persons With HIV Who Use Drugs: The CHAMPS StudyKathleen M Ward, Oluwaseun Falade-Nwulia, Juhi Moon, et al.Digestive Diseases and Sciences|February 9, 2021
Performance of Serum-Based Scores for Identification of Mild Hepatic Steatosis in HBV Mono-infected and HBV-HIV Co-infected AdultsRichard K Sterling, Wendy C King, Mandana Khalili, et al.Pharmacogenetics and Genomics|September 25, 2013
Predictors of consent to pharmacogenomics testing in the IDEAL studyAlison B Jazwinski, Paul J Clark, Alexander J Thompson, et al.Pageof 89